VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $888,279 | -2.9% | 134,792 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $915,237 | +91791.3% | 134,792 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $996 | -99.9% | 134,792 | +31.3% | 0.00% | 0.0% |
| Q3 2022 | $1,014,000 | +33.6% | 102,656 | +47.5% | 0.00% | 0.0% |
| Q2 2022 | $759,000 | -3.6% | 69,588 | 0.0% | 0.00% | – |
| Q1 2022 | $787,000 | +26.1% | 69,588 | +74.8% | 0.00% | – |
| Q4 2021 | $624,000 | – | 39,802 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |